ATE274579T1 - Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus - Google Patents

Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus

Info

Publication number
ATE274579T1
ATE274579T1 AT96923275T AT96923275T ATE274579T1 AT E274579 T1 ATE274579 T1 AT E274579T1 AT 96923275 T AT96923275 T AT 96923275T AT 96923275 T AT96923275 T AT 96923275T AT E274579 T1 ATE274579 T1 AT E274579T1
Authority
AT
Austria
Prior art keywords
bovine coronavirus
bcv
cattle
vaccine against
multivalent vaccine
Prior art date
Application number
AT96923275T
Other languages
English (en)
Inventor
Sanjay Kapil
Original Assignee
Univ Kansas State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas State filed Critical Univ Kansas State
Application granted granted Critical
Publication of ATE274579T1 publication Critical patent/ATE274579T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96923275T 1995-06-12 1996-06-07 Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus ATE274579T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48961495A 1995-06-12 1995-06-12
PCT/US1996/009979 WO1996041874A1 (en) 1995-06-12 1996-06-07 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection

Publications (1)

Publication Number Publication Date
ATE274579T1 true ATE274579T1 (de) 2004-09-15

Family

ID=23944554

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96923275T ATE274579T1 (de) 1995-06-12 1996-06-07 Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus

Country Status (10)

Country Link
US (1) US5916570A (de)
EP (1) EP0833903B1 (de)
AT (1) ATE274579T1 (de)
AU (1) AU705186B2 (de)
CA (1) CA2224309C (de)
DE (1) DE69633233T2 (de)
DK (1) DK0833903T3 (de)
ES (1) ES2224172T3 (de)
PT (1) PT833903E (de)
WO (1) WO1996041874A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040097A2 (en) * 1997-03-10 1998-09-17 Bayer Corporation Bovine respiratory and enteric coronavirus as a vaccine
AU2001264802A1 (en) 2000-05-21 2001-12-03 University Of North Carolina At Chapel Hill Assembly of large viral genomes and chromosomes from subclones
US6974577B2 (en) * 2001-02-04 2005-12-13 Novartris Ag Inactivated bovine scours vaccines, processes and method of preventing bovine scours
US7906311B2 (en) * 2002-03-20 2011-03-15 Merial Limited Cotton rat lung cells for virus culture
GB0217434D0 (en) * 2002-07-27 2002-09-04 Royal Vetinary College Biological material
GB0315323D0 (en) * 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
AU2010273382A1 (en) * 2009-07-17 2012-02-02 The Board Of Regents For Oklahoma State University Supralingual vaccines and applicators
WO2011056175A1 (en) 2009-11-06 2011-05-12 Intervet International B.V. Methods of immunizing pregnant heifers at three months of gestation
KR102243374B1 (ko) * 2019-09-30 2021-04-22 대한민국 소 코로나바이러스, 소 로타바이러스 및 소 바이러스성설사병바이러스에 대한 백신 조성물
KR102234525B1 (ko) * 2020-08-28 2021-03-30 안병철 송아지의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청의 제조방법, 상기 방법에 의해 제조된 혈청 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839556A (en) * 1969-11-28 1974-10-01 Univ Nebraska Calf diarrhea virus vaccine and processes
US3838004A (en) * 1970-11-17 1974-09-24 Univ Nebraska Calf diarrhea virus vaccine and processes
US3869547A (en) * 1971-11-10 1975-03-04 Univ Nebraska Calf diarrhea virus vaccine and processes
US3914408A (en) * 1973-10-12 1975-10-21 Univ Nebraska Vaccine for neonatal calf diarrhea

Also Published As

Publication number Publication date
EP0833903B1 (de) 2004-08-25
CA2224309C (en) 2011-01-25
DK0833903T3 (da) 2005-01-03
DE69633233D1 (de) 2004-09-30
EP0833903A1 (de) 1998-04-08
WO1996041874A1 (en) 1996-12-27
CA2224309A1 (en) 1996-12-27
AU6383296A (en) 1997-01-09
AU705186B2 (en) 1999-05-20
EP0833903A4 (de) 1999-03-24
US5916570A (en) 1999-06-29
ES2224172T3 (es) 2005-03-01
PT833903E (pt) 2004-11-30
DE69633233T2 (de) 2005-08-11

Similar Documents

Publication Publication Date Title
PT815235E (pt) Vacinas para peste
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
ATE274579T1 (de) Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus
ATE197314T1 (de) Verfahren zum vermehren des das reproduktions- und atemwegs-syndrom verursachenden schweinevirus und dessen verwendung als impfstoff.
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
ATE103297T1 (de) Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea.
ATE320444T1 (de) Peptide, die die zytotoxische t-lymphozyte antwort gegen hepatitis-b-virus induzieren
Andrewes et al. Influenza: further experiments on the active immunization of mice
BG102809A (en) Vaccine against the reproductive and respiratory syndrome in pigs
Shope Studies on immunity to swine influenza
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
ATE129900T1 (de) Anwendung von il-4 zur steigerung der immunantwort auf immunogene in impfstoffen.
Olitsky et al. COMPARATIVE STUDIES ON VESICULAR STOMATITIS AND FOOT-AND-MOUTH DISEASE.
JP3109886B2 (ja) 経鼻接種用ワクチン
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ATE295159T1 (de) Bupropion zur behandlung von viralen erkrankungen
Grachev Long-term use of oral poliovirus vaccine from Sabin strains in the Soviet Union
DK257887A (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
Rhodes Immunization Against Polio
FR2792639B1 (fr) Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
RU94038588A (ru) Способ лечения вторичного иммунодефицита (вид)
GERVAIS Acute arterial thrombosis following injury.
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
Shibuta Production of pertussis toxin mutant protein by Bordetella pertussis variant for use in whooping cough vaccine preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0833903

Country of ref document: EP